Cobalt Chromium Toxicity

smith & nephew r3 acetabular system

Smith & Nephew R3 Recall

The Smith & Nephew Reflection 3 (R3) Acetabular Hip was approved via the Food and Drug Administration (FDA) 510k process in 2007. Smith & Nephew Orthopaedics issued a recall for metal liners of the R3 acetabular system on June 1, 2012. The use of Smith & Nephew R3 in total hip replacements is associated with a higher than expected number of revision surgeries, prompting a market withdrawal of the devices.

The metal-on-metal liner is linked to various health issues including but not limited to:

  • infection
  • dislocation
  • metal sensitivity
  • loosening/lysis
  • fracture
  • difficulty walking and pain

Smith & Nephew recommends physicians maintain their typical follow-up protocol for patients who have undergone total hip replacement or resurfacing surgery and implanted with the Smith & Nephew R3. However, this advice can have adverse long-term consequences, both physically and financially.  You should immediately have your blood tested for cobalt and chromium whether or not you have pain, and/or swelling or other unexplained symptoms. Patients with cobalt and chromium levels above 0.3 micrograms per liter (mg/l) or parts per billion (ppb) require monitoring since these levels are abnormal.

You may be entitled to compensatory damages including:

  • lost wages
  • medical expenses
  • cost of disability
  • property loss or repair
  • pain and suffering
  • loss of consortium (if applicable)

Real Time Web Analytics